Market Cap N/A
Revenue (ttm) N/A
Net Income (ttm) N/A
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin N/A
Debt to Equity Ratio N/A
Volume 100
Avg Vol N/A
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K N/A
Beta N/A
Analysts N/A
Price Target N/A

Company Profile

The fund is an actively-managed exchange-traded fund (“ETF”) that pursues its investment objective by investing, under normal circumstances, at least 80% of its net assets plus any borrowings for investment purposes in common stocks, convertible securities, warrants and other equity securities having the characteristics of common stocks of U.S. and foreign companies engaged in medical research, pharmaceutical and medical technology industries and related technology industries. The fund is non-di...

TalkMarkets
TalkMarkets Aug. 9 at 6:40 PM
ETFs In Focus On Eli Lilly's Solid Q2 Earnings, Weak Obesity Data $LLY $IHE $PPH $MEDX $OZEM https://talkmarkets.com/content/etfs/etfs-in-focus-on-eli-lillys-solid-q2-earnings-weak-obesity-data?post=514413&userid=123969
0 · Reply
ZacksResearch
ZacksResearch Aug. 8 at 3:24 PM
$LLY drops hard after strong Q2 — is this the dip to buy? Solid earnings weren’t enough to offset weak obesity drug data, sending shares lower. But top-exposed ETFs like $IHE, $PPH, $MEDX and $MEDI could offer upside. Find out what makes these ETFs worth a closer look 👉 https://www.zacks.com/stock/news/2684363/etfs-in-focus-on-eli-lillys-solid-q2-earnings-weak-obesity-data?cid=sm-stocktwits-2-2684363-teaser-6913&ADID=SYND_STOCKTWITS_TWEET_2_2684363_TEASER_6913
0 · Reply
svertical1
svertical1 Jul. 22 at 2:13 PM
$IBRX Yervoy, but would still work better as combo with Anktiva. The back story is one we all know too well. Yervoy & Optivo 2024 Rev- now 12 B $BMY bought $MEDX (old $CLDX) for 2.4 billion - they got Yervoy and Nivolumab (Optivo), a steal. Thankfully, PSS knows this game well.
2 · Reply
svertical1
svertical1 Jul. 22 at 12:44 PM
$IBRX $BMY $CLDX $MEDX A blast from the past from ‘sogenerous’. These 2 drugs have 2024 sales of nearly 12 Billion. Medarex was bought by BMY for net 2.1B, BP played same games even then. Should’ve been 10X that price minimum.
1 · Reply
PenkeTrading
PenkeTrading Feb. 25 at 5:46 AM
I found you an Overbought RSI (Relative Strength Index) on the daily chart of Horizon Kinetics Medical ETF. Is that bullish or bearish? $MEDX #RsiOverbought #NASDAQ
0 · Reply
PenkeTrading
PenkeTrading Jan. 18 at 4:29 AM
I found you a Bullish Three Line Strike Candle Pattern on the daily chart of Horizon Kinetics Medical ETF. Is that bullish or bearish? $MEDX #BullishThreeLineStrike #NASDAQ
0 · Reply
PenkeTrading
PenkeTrading Nov. 1 at 2:36 AM
I found you an Oversold RSI (Relative Strength Index) on the daily chart of Horizon Kinetics Medical ETF. Is that bullish or bearish? $MEDX #RsiOversold #NASDAQ
0 · Reply
macroaxis
macroaxis Sep. 4 at 11:34 AM
$FNCL - Fidelity MSCI to outpitch Horizon Kinetics ( $MEDX ) in October. https://www.macroaxis.com/invest/pair-correlation/FNCL/MEDX/Fidelity-vs-Horizon #portfolio_prospective #better_portfolio #diversify
0 · Reply
macroaxis
macroaxis Aug. 11 at 7:47 AM
$BBC - Virtus LifeSci is underperforming vs. Horizon Kinetics ( $MEDX ). https://www.macroaxis.com/competition/BBC/MEDX/Virtus-vs-Horizon #portfolio_prospective #better_portfolio #diversify
0 · Reply
tradethehalt
tradethehalt Jan. 31 at 5:01 PM
Mid-Day Top 5 Gainers Report: $ATCX (121%) $THAR (105%) $MGAM (97%) $MEDX (94%) $CNTX (68%) If we missed a split/reverse split, let us know!
0 · Reply
TalkMarkets
TalkMarkets Aug. 9 at 6:40 PM
ETFs In Focus On Eli Lilly's Solid Q2 Earnings, Weak Obesity Data $LLY $IHE $PPH $MEDX $OZEM https://talkmarkets.com/content/etfs/etfs-in-focus-on-eli-lillys-solid-q2-earnings-weak-obesity-data?post=514413&userid=123969
0 · Reply
ZacksResearch
ZacksResearch Aug. 8 at 3:24 PM
$LLY drops hard after strong Q2 — is this the dip to buy? Solid earnings weren’t enough to offset weak obesity drug data, sending shares lower. But top-exposed ETFs like $IHE, $PPH, $MEDX and $MEDI could offer upside. Find out what makes these ETFs worth a closer look 👉 https://www.zacks.com/stock/news/2684363/etfs-in-focus-on-eli-lillys-solid-q2-earnings-weak-obesity-data?cid=sm-stocktwits-2-2684363-teaser-6913&ADID=SYND_STOCKTWITS_TWEET_2_2684363_TEASER_6913
0 · Reply
svertical1
svertical1 Jul. 22 at 2:13 PM
$IBRX Yervoy, but would still work better as combo with Anktiva. The back story is one we all know too well. Yervoy & Optivo 2024 Rev- now 12 B $BMY bought $MEDX (old $CLDX) for 2.4 billion - they got Yervoy and Nivolumab (Optivo), a steal. Thankfully, PSS knows this game well.
2 · Reply
svertical1
svertical1 Jul. 22 at 12:44 PM
$IBRX $BMY $CLDX $MEDX A blast from the past from ‘sogenerous’. These 2 drugs have 2024 sales of nearly 12 Billion. Medarex was bought by BMY for net 2.1B, BP played same games even then. Should’ve been 10X that price minimum.
1 · Reply
PenkeTrading
PenkeTrading Feb. 25 at 5:46 AM
I found you an Overbought RSI (Relative Strength Index) on the daily chart of Horizon Kinetics Medical ETF. Is that bullish or bearish? $MEDX #RsiOverbought #NASDAQ
0 · Reply
PenkeTrading
PenkeTrading Jan. 18 at 4:29 AM
I found you a Bullish Three Line Strike Candle Pattern on the daily chart of Horizon Kinetics Medical ETF. Is that bullish or bearish? $MEDX #BullishThreeLineStrike #NASDAQ
0 · Reply
PenkeTrading
PenkeTrading Nov. 1 at 2:36 AM
I found you an Oversold RSI (Relative Strength Index) on the daily chart of Horizon Kinetics Medical ETF. Is that bullish or bearish? $MEDX #RsiOversold #NASDAQ
0 · Reply
macroaxis
macroaxis Sep. 4 at 11:34 AM
$FNCL - Fidelity MSCI to outpitch Horizon Kinetics ( $MEDX ) in October. https://www.macroaxis.com/invest/pair-correlation/FNCL/MEDX/Fidelity-vs-Horizon #portfolio_prospective #better_portfolio #diversify
0 · Reply
macroaxis
macroaxis Aug. 11 at 7:47 AM
$BBC - Virtus LifeSci is underperforming vs. Horizon Kinetics ( $MEDX ). https://www.macroaxis.com/competition/BBC/MEDX/Virtus-vs-Horizon #portfolio_prospective #better_portfolio #diversify
0 · Reply
tradethehalt
tradethehalt Jan. 31 at 5:01 PM
Mid-Day Top 5 Gainers Report: $ATCX (121%) $THAR (105%) $MGAM (97%) $MEDX (94%) $CNTX (68%) If we missed a split/reverse split, let us know!
0 · Reply
Stock_Titan
Stock_Titan Jan. 30 at 9:35 PM
$SPAQ $MEDX Horizon Kinetics Launches the Horizon Kinetics SPAC Active ETF (SPAQ) and the Horizon Kinetics Medical ETF (MEDX) https://www.stocktitan.net/news/SPAQ/horizon-kinetics-launches-the-horizon-kinetics-spac-active-etf-spaq-jpekwz3myxgg.html
0 · Reply